Publication | Closed Access

First-line Treatment with Ribociclib plus Endocrine Therapy for Premenopausal Women with Hormone-receptor-positive Advanced Breast Cancer: A Cost-effectiveness Analysis

Breast OncologyCost-effectiveness AnalysisMedicineGynecologyEndocrine TherapyBreast CancerPharmacotherapyFirst-line TreatmentOncologyRadiation OncologyEndocrine-related Cancer